BioLine RX Ltd. ADR | Mutual Funds
Mutual Funds that own BioLine RX Ltd. ADR
FCP OP Medical BioHe@lth-Trends
1,357,415
1.26%
0
0.72%
11/30/2017
APO Medical Opportunities
786,243
0.73%
0
0.14%
03/31/2018
APO Medical Opportunities Institutionell
379,308
0.35%
0
0.18%
06/29/2018
Pharma/wHealth Fund
234,297
0.22%
0
0.16%
11/30/2017
178,713
0.17%
0
0.31%
09/06/2018
Fidelity Nasdaq Composite Index
57,628
0.05%
0
0%
07/31/2018
Trust for Professional Managers - PMC Diversified Equity Fund
54,146
0.05%
0
0.01%
05/31/2018
RIM Global - CC Bioscience
41,200
0.04%
28,800
0.28%
06/30/2017
Clal Yeter
35,000
0.03%
0
1.1%
05/31/2018
Market Vectors - Israel ETF
34,928
0.03%
0
0.06%
09/05/2018
| Address |
Modi'in Technology Park
Modi'in TA 7177871
Israel
|
|
Employees
|
- |
| Website |
http://www.biolinerx.com |
| Updated |
07/08/2019 |
| BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel. |
